source
- Dren Bio raises $350 million to advance rare blood cancer antibodyDren Bio, a California biotech, announced a $350 million financing round to fund late‑stage development and commercial preparation of its lead therapy, a CD94‑targeting monoclonal antibody known as…
- Biopharma manufacturing cuts slated to affect over 4,000 workers, with BioNTech leading layoffsCompanies investing billions to reshore drug production are trimming staff at manufacturing sites, with ten biotech and pharma firms planning cuts that could affect more than 4,000 employees. BioN…